Other Industry Partnerships

Myriad is leveraging our industry-leading protein biomarker products and services offered through our Myriad RBM and Crescendo Bioscience subsidiaries. These subsidiaries are partnering with pharmaceutical companies to improve the performance of clinical studies and develop new companion diagnostic applications, such as:

  • Identifying responders versus nonresponders to treatment;
  • Expanding indications for approved drugs/drug re-tasking;
  • Predicting drug toxicity;
  • Therapeutic monitoring; and
  • Pharmacodynamics.

Learn more about Myriad RBM.

Learn more about Crescendo Bioscience.

Illuminating the path to better health through genetic insights

Our tests and screens reveal information to guide patients and providers to better health and well-being. Whether you’re searching for answers related to cancer risk, cancer treatment, prenatal care or mental health, Myriad screens and tests can help.